Animal behavior models of the mechanisms underlying antipsychotic atypicality

This review describes the animal behavior models that provide insight into the mechanisms underlying the critical differences between the actions of typical vs. atypical antipsychotic drugs. Although many of these models are capable of differentiating between antipsychotic and other psychotropic drugs, only a few seem to be able to differentiate between typical and atypical antipsychotics, such as the paw test and the phencyclidine (PCP)-induced disruption of prepulse inhibition (PPI) of startle in rats. Moreover, there is an urgent need for animal models focusing more on the negative and the cognitive symptoms. Hence, improved animal models are crucial for developing better treatments for schizophrenia.

[1]  A. Mcghie,et al.  Disorders of attention and perception in early schizophrenia. , 1961, The British journal of medical psychology.

[2]  M. Carlsson The selective 5-HT2a receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse — implications for psychosis , 2005, Journal of Neural Transmission / General Section JNT.

[3]  M. Geyer,et al.  Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats , 1994, Neuropharmacology.

[4]  M. Geyer,et al.  Ontogeny of Isolation Rearing-Induced Deficits in Sensorimotor Gating in Rats , 1999, Physiology & Behavior.

[5]  C. Sánchez,et al.  Neurochemical and in vivo pharmacological profile of sertindole, a limbic‐selective neuroleptic compound , 1991 .

[6]  R. Lubow,et al.  Disruption of latent inhibition by acute administration of low doses of amphetamine , 1988, Pharmacology Biochemistry and Behavior.

[7]  J. Malick,et al.  Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug , 2005, Psychopharmacology.

[8]  A. Cools,et al.  Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: Tonic EMG activity in rats , 1985, Brain Research.

[9]  J. Rawlins,et al.  Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment , 1998, British Journal of Psychiatry.

[10]  J. Strauss,et al.  Part 1: The Concept of Premorbid Adjustment* , 1977 .

[11]  M. Geyer,et al.  Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle , 1991, Biological Psychiatry.

[12]  B. Ellenbroek,et al.  Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs. , 1993, Pharmacology & therapeutics.

[13]  J. Arnt Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine. , 1995, European journal of pharmacology.

[14]  Dennis S. Charney,et al.  Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .

[15]  T. Skarsfeldt Differential effect of antipsychotics on place navigation of rats in the Morris water maze , 1996, Psychopharmacology.

[16]  M. Pietraszek,et al.  Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[17]  M. Geyer,et al.  Multiple Limbic Regions Mediate the Disruption of Prepulse Inhibition Produced in Rats by the Noncompetitive NMDA Antagonist Dizocilpine , 1998, The Journal of Neuroscience.

[18]  R. Padich,et al.  5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats , 1996, Psychopharmacology.

[19]  M A Geyer,et al.  Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. , 1999, The Journal of pharmacology and experimental therapeutics.

[20]  A. Malhotra,et al.  Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine , 1997, Biological Psychiatry.

[21]  T. Sharma,et al.  Normalization of information processing deficits in schizophrenia with clozapine. , 1999, The American journal of psychiatry.

[22]  I. Weiner,et al.  From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. , 1992, Journal of psychiatric research.

[23]  J. Slangen,et al.  Animal Models in Psychopharmacology , 1991, APS: Advances in Pharmacological Sciences.

[24]  G. Rose,et al.  Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol , 1986, Biological Psychiatry.

[25]  A. Cools,et al.  The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine , 1995, Psychopharmacology.

[26]  J. Kehne,et al.  Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. , 1992, The Journal of pharmacology and experimental therapeutics.

[27]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[28]  G. Ma,et al.  Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. , 1989 .

[29]  R Freedman,et al.  Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. , 1982, Biological psychiatry.

[30]  A. Cools,et al.  The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs , 2004, Psychopharmacology.

[31]  M. Geyer,et al.  Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine , 2005, Psychopharmacology.

[32]  H. Struyker-Boudier,et al.  (3,4‐Dihydroxyphenylimino)‐2‐imidazoline (DPI): a stimulant of α‐adrenoceptors and dopamine receptors , 1984 .

[33]  D. Javitt,et al.  Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys , 2001, Neuroreport.

[34]  D. Casey Behavioral effects of sertindole, risperidone, clozapine and haloperidol inCebus monkeys , 1996, Psychopharmacology.

[35]  The nucleus accumbens and forelimb muscular rigidity in rats , 2004, Experimental Brain Research.

[36]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[37]  J. Gray,et al.  Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET , 1995, Schizophrenia Research.

[38]  N. Swerdlow,et al.  Effects of LU-111995 in three models of disrupted prepulse inhibition in rats. , 1999, The Journal of pharmacology and experimental therapeutics.

[39]  M. Geyer,et al.  DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum , 1997, Brain Research.

[40]  A. Cools,et al.  Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia. , 2001, The Journal of pharmacology and experimental therapeutics.

[41]  A. Cools,et al.  Animal models of schizophrenia , 2000 .

[42]  A. Dickinson,et al.  Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction , 1994, Psychopharmacology.

[43]  N. Moore,et al.  The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. , 1992, The Journal of pharmacology and experimental therapeutics.

[44]  Bob Oranje,et al.  P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study , 1999, Biological Psychiatry.

[45]  Trevor W. Robbins,et al.  Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia , 1993, Biological Psychiatry.

[46]  M. Geyer,et al.  Psychopharmacology of prepulse inhibition in mice. , 1996, The Chinese journal of physiology.

[47]  A. Cools,et al.  Activity of “Seroquel” (ICI 204,636) in Animal Models for Atypical Properties of Antipsychotics: A Comparison with Clozapine , 1996, Neuropsychopharmacology.

[48]  D. Javitt,et al.  Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys , 2003, Psychopharmacology.

[49]  David L. Braff,et al.  Latent inhibition in schizophrenia , 1996, Schizophrenia Research.

[50]  C. Niemegeers,et al.  IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS. , 1965, Arzneimittel-Forschung.

[51]  B. Ellenbroek The Ethological Analysis of Monkeys in a Social Setting as an Animal Model for Schizophrenia , 1991 .

[52]  D L Braff,et al.  Sensorimotor gating and schizophrenia. Human and animal model studies. , 1990, Archives of general psychiatry.

[53]  M. Geyer,et al.  The Effects of M100907 in Pharmacological and Developmental Animal Models of Prepulse Inhibition Deficits in Schizophrenia , 1999, Neuropsychopharmacology.

[54]  J. Arnt,et al.  Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. , 2009, Acta pharmacologica et toxicologica.

[55]  M. Geyer,et al.  Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. , 1997, The Journal of pharmacology and experimental therapeutics.

[56]  A. Cools,et al.  The Paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism. , 1988, Life sciences.

[57]  N. Swerdlow,et al.  Startle response models of sensorimotor gating and habituation deficits in schizophrenia , 1990, Brain Research Bulletin.

[58]  H. Shannon,et al.  Behavioral pharmacology of olanzapine: a novel antipsychotic drug. , 1997, The Journal of clinical psychiatry.

[59]  N. Swerdlow,et al.  Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. , 1994, The Journal of pharmacology and experimental therapeutics.

[60]  M. Geyer,et al.  Characterization of the Disruptions of Prepulse Inhibition and Habituation of Startle Induced by α-Ethyltryptamine , 1997, Neuropsychopharmacology.

[61]  N. Swerdlow,et al.  Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. , 1994, Archives of general psychiatry.

[62]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[63]  M. Geyer,et al.  Dopaminergic stimulation disrupts sensorimotor gating in the rat , 2004, Psychopharmacology.

[64]  D L Braff,et al.  Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. , 1999, Archives of general psychiatry.

[65]  N. Swerdlow,et al.  The neural substrates for the motor-activating properties of psychostimulants: A review of recent findings , 1986, Pharmacology Biochemistry and Behavior.

[66]  H. Shannon,et al.  Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice , 1997, Psychopharmacology.

[67]  N. Swerdlow,et al.  Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats , 1998, Psychopharmacology.

[68]  M. Olkinuora,et al.  Agranulocytosis during treatment with clozapine , 1977, European Journal of Clinical Pharmacology.

[69]  D L Braff,et al.  Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. , 2000, The American journal of psychiatry.

[70]  F. Sams-Dodd Phencyclidine‐induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia , 1996, Behavioural pharmacology.

[71]  J. Schwartz,et al.  Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum , 1976, Psychopharmacology.

[72]  A. Cools Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens , 2004, Psychopharmacology.

[73]  M. Geyer,et al.  Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat. , 1989, European journal of pharmacology.

[74]  F. Colpaert,et al.  Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics. , 1993, The Journal of pharmacology and experimental therapeutics.

[75]  A. Cools,et al.  Sensory gating in rats: lack of correlation between auditory evoked potential gating and prepulse inhibition. , 1999, Schizophrenia bulletin.

[76]  N. Swerdlow,et al.  Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics , 1986, Biological Psychiatry.

[77]  J. Barrett,et al.  Antipsychotic drug effects on the behavior of squirrel monkeys differentially controlled by noxious stimuli , 2004, Psychopharmacology.

[78]  Robert Freedman,et al.  Gating of auditory P50 in schizophrenics: Unique effects of clozapine , 1996, Biological Psychiatry.

[79]  A. Carlsson,et al.  Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone , 1998, Journal of Neural Transmission.

[80]  H. Hartman,et al.  Effects of atypical antipsychotic agents on social behavior in rodents , 1993, Pharmacology Biochemistry and Behavior.

[81]  J. Schwartz,et al.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[82]  J. Gray,et al.  Differential Performance of Acute and Chronic Schizophrenics in a Latent Inhibition Task , 1988, The Journal of nervous and mental disease.

[83]  G. Rose,et al.  Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating , 1991, Brain Research.

[84]  K. Miczek,et al.  Disruption of primate social behavior by d-amphetamine and cocaine: Differential antagonism by antipsychotics , 2004, Psychopharmacology.

[85]  M. Geyer,et al.  M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats , 1999, Neuropsychopharmacology.

[86]  T. Robbins,et al.  Social Isolation in the Rat Produces Developmentally Specific Deficits in Prepulse Inhibition of the Acoustic Startle Response Without Disrupting Latent Inhibition , 1994, Neuropsychopharmacology.

[87]  A. Cools,et al.  The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm , 1997, Psychopharmacology.

[88]  M. Geyer,et al.  Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats. , 1998, Behavioral neuroscience.

[89]  D. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[90]  D L Braff,et al.  Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.

[91]  A. Cools,et al.  Simulation models for schizophrenia , 2000 .